Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
TNBC Study Identifies Drug Resistant Cell States
May 2026
Researchers identified persistent drug tolerant cell states in TNBC that survive chemotherapy and may drive metastatic progression and treatment resistance.
Read more
14 Feb 2024
New Treatment for Liver Cancer May Improve Survival
This research has the potential to alter the global standard of care for patients with hepatocellular carcinoma, which for more than 20 years has been treatment with TACE alone.
13 Feb 2024
New Immunotherapy Combinations for Patients with Oesophageal Cancer
Findings from a new Phase III study show promise for the dual approach of chemotherapy and immunotherapy as a first-line treatment for advanced oesophageal squamous cell carcinoma.
12 Feb 2024
Exploring Circulating Tumour DNA as a Prognostic Tool in Colon Cancer
The NRG-GI005 (COBRA) Phase II/III study, the first of its kind, aimed to assess ctDNA clearance as a primary endpoint…
9 Feb 2024
Circulating Tumour DNA for Monitoring and Detecting Molecular Residual Disease
CtDNA may be used to detect molecular residual disease (MRD) in patients, and to monitor the effectiveness of treatment of patients…
8 Feb 2024
Advances in Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumours
Patients with high-grade gastroenteropancreatic neuroendocrine tumours showed…
29 Jan 2024
Higher Hospital Mortality in Patients with Ovarian Cancer from Underrepresented Groups
Females with ovarian cancer have a higher likelihood of hospital mortality if they are Black, American Indian, Asian, and Hispanic, when compared with their White counterparts, according to a recent study.
26 Jan 2024
Pyogenic Liver Abscess Increases Colorectal Cancer Risk
Patients diagnosed with cryptogenic pyogenic liver abscess had a significantly higher incidence of colorectal cancer up to 3 years after PLA diagnosis compared with control patients, according to recent data.
24 Nov 2023
Racial, Socioeconomic, and Geographic Disparities Affect Cancer Mortality Risk
An updated report from the ACS revealed that individuals with a lower socioeconomic status, populations living in non-metropolitan areas, and Black and American Indian/Alaska Native individuals bear a disproportionately higher burden of cancer-related deaths.
Loading posts...
« Previous
1
…
37
38
39
40
41
…
66
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View